Quantcast
Last updated on April 24, 2014 at 1:21 EDT

Latest Respiratory diseases Stories

2014-04-17 08:27:44

Potential to Provide Needed Breathing Support for Patients with Neuromuscular Diseases and Non-Oxygen Dependent Respiratory Diseases IRVINE, Calif., April 17, 2014 /PRNewswire/ -- Breathe Technologies, Inc. announced today that the U.S. Food and Drug Administration (FDA) has granted the fifth 510(k) clearance for its Non-Invasive Open Ventilation (NIOV) System, allowing its use with compressed air supply for non-oxygen dependent patients. The previous four FDA clearances cover the...

2014-04-11 12:24:06

DUBLIN, Ireland, April 11, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/53hl65/global) has announced the addition of the "Global Epinephrine Auto-Injector Market Report" [http://www.researchandmarkets.com/research/53hl65/global ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) The analysts forecast the Global Epinephrine Auto-injector market to grow at a CAGR of 13.34 percent over the...

2014-03-10 23:04:07

The 47 billion-dollar worldwide respiratory device market continues to grow mainly due to the aging of the world population and increasing incidence of respiratory diseases, according to Kalorama Information in the new report “The World Market for Respiratory Devices.” New York, NY (PRWEB) March 10, 2014 The 47 billion-dollar worldwide respiratory device market continues to grow mainly due to the aging of the world population and increasing incidence of respiratory diseases, according...

2014-03-03 23:03:07

Food Allergy Research & Education is helping to establish the Allergy, Asthma & Immunology Education and Research Organization, Inc.’s (ARTrust™) $4 million Donald Leung and JACI Editors Allergy/Immunology Research Fund to provide ongoing support for research in the field of allergy, asthma and immunologic diseases, in keeping with its commitment to attract the most talented investigators to the field of food allergy. McLean, VA (PRWEB) March 03, 2014 At the 2014 Annual...

2014-03-01 12:20:28

Two poster presentations will highlight initial findings from The Anaphylaxis Risk Assessment (TARA) study, one of the largest U.S. managed care retrospective database reviews to date PITTSBURGH, March 1, 2014 /PRNewswire/ -- Mylan Specialty will present initial data from The Anaphylaxis Risk Assessment (TARA) study at the 2014 Annual Meeting of the American Academy of Allergy, Asthma and Immunology (AAAAI) held in San Diego, Calif., Feb. 28 - March 4. TARA aims to uncover factors associated...

2014-02-26 16:27:17

AMHERST, N.Y., Feb. 26, 2014 /PRNewswire/ -- ONY, Inc., a pioneer in neonatal pharmaceutical development, has reached an agreement with Recordati Rare Diseases to co-promote NeoProfen(®) (ibuprofen lysine) Injection. (Logo: http://photos.prnewswire.com/prnh/20140226/CL72787LOGO ) NeoProfen® is indicated to close a clinically significant Patent Ductus Arteriosis (PDA) in premature infants weighing between 500 and 1500 grams, who are no more than 32 weeks gestational age when...

2014-02-07 16:24:13

TORONTO, Feb. 7, 2014 /CNW/ - Pfizer Canada Inc., the Canadian distributor of EpiPen® (epinephrine) Auto Injector is proud to announce its entry in the 2014 NASCAR Canadian Tire Series as the title sponsor of Alex Tagliani's No. 18 car. "Pfizer is pleased to be entering the NASCAR Canadian Tire Series as Alex Tagliani's title sponsor," said Allen Van Der Wee, General Manager, Global Established Products Business Unit at Pfizer Canada Inc. "We are looking forward to partnering...

2014-01-06 12:28:29

RICHMOND, Va., Jan. 6, 2014 /PRNewswire/ -- Intelliject, Inc. a pharmaceutical company based in Richmond, VA has announced that its company name has been changed to kaleo, Inc. In normal usage, the company will be known as kaleo. Announcing the change, Spencer Williamson, President and CEO of kaleo said, "We are excited that our new name, kaleo, will help to communicate our future as a leader in developing a new generation of personal lifesaving medical products." "The name kaleo is...

2013-12-18 08:29:04

Thousands of Hands Raised Demonstrate Nationwide Call for Increased Awareness of Life-Threatening Allergies PITTSBURGH, Dec. 18, 2013 /PRNewswire/ -- Today, Emmy(®)-award winning actress Julie Bowen joined Mylan Specialty to announce the four winning school districts of the Raise Your Hand for Anaphylaxis Awareness(TM) competition. As part of the larger Get Schooled in Anaphylaxis(TM) initiative, the competition called for local communities to educate others in the school environment to...

2013-12-18 08:28:24

KONTICH, Belgium, December 18, 2013 /PRNewswire/ -- FLUIDDA develops proprietary Functional Respiratory Imaging (FRI) technology that provides a unique entry point into personalized medicine for respiratory diseases. FRI reduces significantly the number of patients needed in clinical trials, resulting in better drugs coming to the market faster. FLUIDDA is invited by the FDA to present the benefits of this unique technology for the screening of new respiratory drugs....